Cardiol Therapeutics (CRDL) Common Equity: 2021
Historic Common Equity for Cardiol Therapeutics (CRDL) over the last 1 years, with Dec 2021 value amounting to $60.8 million.
Historic Common Equity for Cardiol Therapeutics (CRDL) over the last 1 years, with Dec 2021 value amounting to $60.8 million.